Advertisement
Screener

DAVITA INC. (DVA) Net Income (Loss) Attributable to Noncontrolling Interest

2.0 / 5 stars · 43/110 Roast Me

DAVITA INC. Net Income (Loss) Attributable to Noncontrolling Interest

DAVITA INC. (DVA) reported Net Income (Loss) Attributable to Noncontrolling Interest of $77.83 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-04

  • DAVITA INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $77.83M, a 2.56% increase year-over-year.
  • DAVITA INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was $77.50M, a 11.84% increase year-over-year.
  • DAVITA INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $96.81M, a 7.67% increase year-over-year.
  • DAVITA INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was $89.92M, a 10.91% increase year-over-year.
  • DAVITA INC. net income (loss) attributable to noncontrolling interest for fiscal 2025 was $331.91M, a 5.57% increase from fiscal 2024.
  • DAVITA INC. net income (loss) attributable to noncontrolling interest for fiscal 2024 was $314.39M, a 18.44% increase from fiscal 2023.
  • DAVITA INC. net income (loss) attributable to noncontrolling interest for fiscal 2023 was $265.44M, a 19.98% increase from fiscal 2022.
  • DAVITA INC. net income (loss) attributable to noncontrolling interest for fiscal 2022 was $221.24M, a 5.17% decline from fiscal 2021.
Period endNet Income (Loss) Attributable to Noncontrolling Interest 3 monthNet Income (Loss) Attributable to Noncontrolling Interest 6 monthNet Income (Loss) Attributable to Noncontrolling Interest 9 monthNet Income (Loss) Attributable to Noncontrolling Interest 12 month
2026-06-30$77.83M
10-Q · filed 2026-08-04
$155.33M
10-Q · filed 2026-08-04
$252.15M
derived: sum of 3 quarters · filed 2026-08-04
$342.06M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$77.50M
10-Q · filed 2026-05-05
$174.32M
derived: sum of 2 quarters · filed 2026-05-05
$264.24M
derived: sum of 3 quarters · filed 2026-05-05
$340.12M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$96.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$186.73M
derived: sum of 2 quarters · filed 2026-02-11
$262.61M
derived: sum of 3 quarters · filed 2026-08-04
$331.91M
10-K · filed 2026-02-11
2025-09-30$89.92M
10-Q · filed 2025-10-29
$165.80M
derived: sum of 2 quarters · filed 2026-08-04
$235.10M
10-Q · filed 2025-10-29
$325.01M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$75.88M
10-Q · filed 2026-08-04
$145.18M
10-Q · filed 2026-08-04
$235.10M
derived: sum of 3 quarters · filed 2026-08-04
$316.17M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$69.30M
10-Q · filed 2026-05-05
$159.22M
derived: sum of 2 quarters · filed 2026-05-05
$240.29M
derived: sum of 3 quarters · filed 2026-05-05
$317.36M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$89.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$170.99M
derived: sum of 2 quarters · filed 2026-02-11
$248.06M
derived: sum of 3 quarters · filed 2026-02-11
$314.39M
10-K · filed 2026-02-11
2024-09-30$81.07M
10-Q · filed 2025-10-29
$158.15M
derived: sum of 2 quarters · filed 2025-10-29
$224.48M
10-Q · filed 2025-10-29
$304.39M
derived: sum of 4 quarters · filed 2026-02-11
2024-06-30$77.08M
10-Q · filed 2025-08-05
$143.41M
10-Q · filed 2025-08-05
$223.31M
derived: sum of 3 quarters · filed 2026-02-11
$286.04M
derived: sum of 4 quarters · filed 2026-02-11
2024-03-31$66.33M
10-Q · filed 2025-05-12
$146.24M
derived: sum of 2 quarters · filed 2026-02-11
$208.97M
derived: sum of 3 quarters · filed 2026-02-11
$276.65M
derived: sum of 4 quarters · filed 2026-02-11
2023-12-31$79.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$142.64M
derived: sum of 2 quarters · filed 2026-02-11
$210.32M
derived: sum of 3 quarters · filed 2026-02-11
$265.44M
10-K · filed 2026-02-11
2023-09-30$62.73M
10-Q · filed 2024-10-29
$130.41M
derived: sum of 2 quarters · filed 2024-10-29
$185.54M
10-Q · filed 2024-10-29
$244.05M
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30$67.69M
10-Q · filed 2024-08-06
$122.81M
10-Q · filed 2024-08-06
$181.32M
derived: sum of 3 quarters · filed 2025-02-13
$240.65M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31$55.12M
10-Q · filed 2024-05-02
$113.63M
derived: sum of 2 quarters · filed 2025-02-13
$172.96M
derived: sum of 3 quarters · filed 2025-02-13
$232.77M
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31$58.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$117.84M
derived: sum of 2 quarters · filed 2025-02-13
$177.65M
derived: sum of 3 quarters · filed 2025-02-13
$221.24M
10-K · filed 2025-02-13
2022-09-30$59.33M
10-Q · filed 2023-11-07
$119.14M
derived: sum of 2 quarters · filed 2023-11-07
$162.73M
10-Q · filed 2023-11-07
$224.69M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-30$59.81M
10-Q · filed 2023-08-03
$103.40M
10-Q · filed 2023-08-03
$165.36M
derived: sum of 3 quarters · filed 2024-02-14
$225.36M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-31$43.60M
10-Q · filed 2023-05-08
$105.56M
derived: sum of 2 quarters · filed 2024-02-14
$165.56M
derived: sum of 3 quarters · filed 2024-02-14
$222.77M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-31$61.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$121.96M
derived: sum of 2 quarters · filed 2024-02-14
$179.17M
derived: sum of 3 quarters · filed 2024-02-14
$233.31M
10-K · filed 2024-02-14
2021-09-30$60.00M
10-Q · filed 2022-10-31
$117.21M
derived: sum of 2 quarters · filed 2022-10-31
$171.35M
10-Q · filed 2022-10-31
$231.95M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$57.21M
10-Q · filed 2022-08-01
$111.35M
10-Q · filed 2022-08-01
$171.95M
derived: sum of 3 quarters · filed 2023-02-22
$230.82M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$54.14M
10-Q · filed 2022-05-05
$114.74M
derived: sum of 2 quarters · filed 2023-02-22
$173.60M
derived: sum of 3 quarters · filed 2023-02-22
$226.88M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31$60.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$119.46M
derived: sum of 2 quarters · filed 2023-02-22
$172.73M
derived: sum of 3 quarters · filed 2023-02-22
$221.03M
10-K · filed 2023-02-22
2020-09-30$58.87M
10-Q · filed 2021-10-28
$112.14M
derived: sum of 2 quarters · filed 2021-10-28
$160.44M
10-Q · filed 2021-10-28
$218.53M
derived: sum of 4 quarters · filed 2022-02-11
2020-06-30$53.27M
10-Q · filed 2021-08-03
$101.57M
10-Q · filed 2021-08-03
$159.66M
derived: sum of 3 quarters · filed 2022-02-11
$218.08M
derived: sum of 4 quarters · filed 2022-02-11
2020-03-31$48.30M
10-Q · filed 2021-04-29
$106.39M
derived: sum of 2 quarters · filed 2022-02-11
$164.81M
derived: sum of 3 quarters · filed 2022-02-11
$218.42M
derived: sum of 4 quarters · filed 2022-02-11
2019-12-31$58.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11
$116.51M
derived: sum of 2 quarters · filed 2022-02-11
$170.12M
derived: sum of 3 quarters · filed 2022-02-11
$210.31M
10-K · filed 2022-02-11
2019-09-30$58.42M
10-Q · filed 2020-10-29
$112.02M
derived: sum of 2 quarters · filed 2020-10-29
$152.22M
10-Q · filed 2020-10-29
$200.15M
derived: sum of 4 quarters · filed 2021-02-12
2019-06-30$53.61M
10-Q · filed 2020-07-30
$93.80M
10-Q · filed 2020-07-30
$141.73M
derived: sum of 3 quarters · filed 2021-02-12
$181.86M
derived: sum of 4 quarters · filed 2021-02-12
2019-03-31$40.20M
10-Q · filed 2020-05-05
$88.13M
derived: sum of 2 quarters · filed 2021-02-12
$128.25M
derived: sum of 3 quarters · filed 2021-02-12
$167.30M
derived: sum of 4 quarters · filed 2021-02-12
2018-12-31$47.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12
$88.06M
derived: sum of 2 quarters · filed 2021-02-12
$127.10M
derived: sum of 3 quarters · filed 2021-02-12
$173.65M
10-K · filed 2021-02-12
2018-09-30$40.13M
10-Q · filed 2019-11-07
$79.17M
derived: sum of 2 quarters · filed 2019-11-07
$125.72M
10-Q · filed 2019-11-07
$163.00M
derived: sum of 4 quarters · filed 2020-02-21
2018-06-30$39.05M
10-Q · filed 2019-08-02
$85.59M
10-Q · filed 2019-08-02
$122.87M
derived: sum of 3 quarters · filed 2020-02-21
$165.31M
derived: sum of 4 quarters · filed 2020-02-21
2018-03-31$46.54M
10-Q · filed 2019-05-07
$83.83M
derived: sum of 2 quarters · filed 2020-02-21
$126.27M
derived: sum of 3 quarters · filed 2020-02-21
$160.89M
derived: sum of 4 quarters · filed 2020-02-21
2017-12-31$37.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21
$79.72M
derived: sum of 2 quarters · filed 2020-02-21
$114.35M
derived: sum of 3 quarters · filed 2020-02-21
$166.94M
10-K · filed 2020-02-21
2017-09-30$42.44M
10-Q · filed 2018-11-07
$77.07M
derived: sum of 2 quarters · filed 2018-11-07
$129.65M
10-Q · filed 2018-11-07
$160.20M
derived: sum of 4 quarters · filed 2019-02-22
2017-06-30$34.62M
10-Q · filed 2018-08-01
$87.21M
10-Q · filed 2018-08-01
$117.76M
derived: sum of 3 quarters · filed 2019-02-22
$158.57M
derived: sum of 4 quarters · filed 2019-02-22
2017-03-31$52.59M
10-Q · filed 2018-05-03
$83.13M
derived: sum of 2 quarters · filed 2019-02-22
$123.95M
derived: sum of 3 quarters · filed 2019-02-22
$165.07M
derived: sum of 4 quarters · filed 2019-02-22
2016-12-31$30.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
$71.36M
derived: sum of 2 quarters · filed 2019-02-22
$112.48M
derived: sum of 3 quarters · filed 2019-02-22
$153.21M
10-K · filed 2019-02-22
2016-09-30$40.82M
10-Q · filed 2017-11-07
$81.94M
derived: sum of 2 quarters · filed 2017-11-07
$122.66M
10-Q · filed 2017-11-07
$163.14M
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30$41.12M
10-Q · filed 2017-08-01
$81.85M
10-Q · filed 2017-08-01
$122.32M
derived: sum of 3 quarters · filed 2018-02-23
$167.75M
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31$40.73M
10-Q · filed 2017-05-02
$81.20M
derived: sum of 2 quarters · filed 2018-02-23
$126.63M
derived: sum of 3 quarters · filed 2018-02-23
$163.93M
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31$40.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$85.91M
derived: sum of 2 quarters · filed 2018-02-23
$123.21M
derived: sum of 3 quarters · filed 2018-02-23
$157.68M
10-K · filed 2018-02-23
2015-09-30$45.44M
10-Q · filed 2016-11-02
$82.73M
derived: sum of 2 quarters · filed 2016-11-02
$117.20M
10-Q · filed 2016-11-02
$159.57M
derived: sum of 4 quarters · filed 2017-02-24
2015-06-30$37.30M
10-Q · filed 2016-08-08
$71.77M
10-Q · filed 2016-08-08
$114.14M
derived: sum of 3 quarters · filed 2017-02-24
$149.80M
derived: sum of 4 quarters · filed 2017-02-24
2015-03-31$34.47M
10-Q · filed 2016-05-04
$76.84M
derived: sum of 2 quarters · filed 2017-02-24
$112.50M
derived: sum of 3 quarters · filed 2017-02-24
$146.24M
derived: sum of 4 quarters · filed 2017-02-24
2014-12-31$42.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$78.03M
derived: sum of 2 quarters · filed 2017-02-24
$111.77M
derived: sum of 3 quarters · filed 2017-02-24
$140.22M
10-K · filed 2017-02-24
2014-09-30$35.66M
10-Q · filed 2015-11-05
$69.40M
derived: sum of 2 quarters · filed 2015-11-05
$97.85M
10-Q · filed 2015-11-05
$129.84M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$33.74M
10-Q · filed 2015-08-05
$62.19M
10-Q · filed 2015-08-05
$94.18M
derived: sum of 3 quarters · filed 2016-02-26
$127.39M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$28.45M
10-Q/A · filed 2015-05-08
$60.44M
derived: sum of 2 quarters · filed 2016-02-26
$93.65M
derived: sum of 3 quarters · filed 2016-02-26
$122.63M
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31$32.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$65.20M
derived: sum of 2 quarters · filed 2016-02-26
$94.19M
derived: sum of 3 quarters · filed 2016-02-26
$123.75M
10-K · filed 2016-02-26
2013-09-30$33.21M
10-Q · filed 2014-11-06
$62.19M
derived: sum of 2 quarters · filed 2014-11-06
$91.76M
10-Q · filed 2014-11-06
$119.72M
derived: sum of 4 quarters · filed 2015-02-26
2013-06-30$28.98M
10-Q · filed 2014-08-01
$58.55M
10-Q · filed 2014-08-01
$86.51M
derived: sum of 3 quarters · filed 2015-02-26
$114.34M
derived: sum of 4 quarters · filed 2015-02-26
2013-03-31$29.57M
10-Q · filed 2014-05-02
$57.53M
derived: sum of 2 quarters · filed 2015-02-26
$85.36M
derived: sum of 3 quarters · filed 2015-02-26
$110.03M
derived: sum of 4 quarters · filed 2015-02-26
2012-12-31$27.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26
$55.79M
derived: sum of 2 quarters · filed 2015-02-26
$80.46M
derived: sum of 3 quarters · filed 2015-02-26
$105.22M
10-K · filed 2015-02-26
2012-09-30$27.83M
10-Q · filed 2013-11-06
$52.50M
derived: sum of 2 quarters · filed 2013-11-06
$77.26M
10-Q · filed 2013-11-06
$105.27M
derived: sum of 4 quarters · filed 2014-02-21
2012-06-30$24.67M
10-Q · filed 2013-08-07
$49.43M
10-Q · filed 2013-08-07
$77.44M
derived: sum of 3 quarters · filed 2014-02-21
$103.92M
derived: sum of 4 quarters · filed 2014-02-21
2012-03-31$24.76M
10-Q · filed 2013-05-09
$52.77M
derived: sum of 2 quarters · filed 2014-02-21
$79.26M
derived: sum of 3 quarters · filed 2014-02-21
$99.91M
derived: sum of 4 quarters · filed 2014-02-21
2011-12-31$28.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21
$54.49M
derived: sum of 2 quarters · filed 2014-02-21
$75.14M
derived: sum of 3 quarters · filed 2014-02-21
$95.39M
10-K · filed 2014-02-21
2011-09-30$26.48M
10-Q · filed 2012-10-31
$47.13M
derived: sum of 2 quarters · filed 2012-10-31
$67.39M
10-Q · filed 2012-10-31
$90.81M
derived: sum of 4 quarters · filed 2013-03-01
2011-06-30$20.65M
10-Q · filed 2012-08-03
$40.90M
10-Q · filed 2012-08-03
$64.33M
derived: sum of 3 quarters · filed 2013-03-01
$87.82M
derived: sum of 4 quarters · filed 2013-03-01
2011-03-31$20.25M
10-Q · filed 2012-05-02
$43.67M
derived: sum of 2 quarters · filed 2013-03-01
$67.17M
derived: sum of 3 quarters · filed 2013-03-01
$83.21M
derived: sum of 4 quarters · filed 2013-03-01
2010-12-31$23.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01
$46.92M
derived: sum of 2 quarters · filed 2013-03-01
$62.96M
derived: sum of 3 quarters · filed 2013-03-01
$78.54M
10-K · filed 2013-03-01
2010-09-30$23.49M
10-Q · filed 2011-11-04
$39.53M
derived: sum of 2 quarters · filed 2011-11-04
$55.11M
10-Q · filed 2011-11-04
$70.97M
derived: sum of 4 quarters · filed 2012-07-06
2010-06-30$16.04M
10-Q · filed 2011-08-04
$31.62M
10-Q · filed 2011-08-04
$47.48M
derived: sum of 3 quarters · filed 2012-07-06
$62.82M
derived: sum of 4 quarters · filed 2012-07-06
2010-03-31$15.58M
10-Q · filed 2011-05-06
$31.44M
derived: sum of 2 quarters · filed 2012-07-06
$46.78M
derived: sum of 3 quarters · filed 2012-07-06
$60.59M
derived: sum of 4 quarters · filed 2012-07-06
2009-12-31$15.86M
derived: 8-K 12 month − 10-Q 9 month · filed 2012-07-06
$31.20M
derived: sum of 2 quarters · filed 2012-07-06
$45.01M
derived: sum of 3 quarters · filed 2012-07-06
$57.08M
8-K · filed 2012-07-06
2009-09-30$15.34M
10-Q · filed 2010-11-05
$29.15M
derived: sum of 2 quarters · filed 2010-11-05
$41.22M
10-Q · filed 2010-11-05
$52.60M
derived: sum of 4 quarters · filed 2011-02-25
2009-06-30$13.81M
10-Q · filed 2010-08-05
$25.88M
10-Q · filed 2010-08-05
$37.26M
derived: sum of 3 quarters · filed 2011-02-25
$51.09M
derived: sum of 4 quarters · filed 2011-02-25
2009-03-31$12.06M
10-Q · filed 2010-05-03
$23.44M
derived: sum of 2 quarters · filed 2011-02-25
$37.27M
derived: sum of 3 quarters · filed 2011-02-25
2008-12-31$11.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25
$25.21M
derived: sum of 2 quarters · filed 2011-02-25
$47.16M
10-K · filed 2011-02-25
2008-09-30$13.83M
10-Q · filed 2009-11-05
$35.78M
10-Q · filed 2009-11-05
2007-12-31$46.87M
10-K · filed 2010-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sotera Health Co (SHC)United States$5.271B30.96
Progyny, Inc. (PGNY)United States$1.994B28.37
agilon health, inc. (AGL)United States$1.272B-7.76
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43